JNJ · Johnson & Johnson
United States · RS rating 83 · As of 2026-11-03
| Price | 266.17 USD |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 83 / 72 / 74 / 82 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 50 / 56 / 53 |
| Industry group (rank) | Medical-Diversified (4) |
| EPS growth Q/Q | -0.9% |
| Sales growth Q/Q | +2.4% |
| Distance from 52-week high | +4.4% |
| Market cap (USD) | $555.2B |